Stay updated with breaking news from Corp Comms. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.
UTRECHT, The Netherlands and CAMBRIDGE, Mass., Aug. 09, 2023 (GLOBE NEWSWIRE) -- Merus N.V. (NASDAQ:MRUS) ("Merus", the "Company," "we" and "our"), a clinical-stage oncology company developing innovative, full-length
Planview the leading platform for digital connected work from portfolio planning to delivery today announced a firsttomarket offeringDigital Product Insightsthat combines portfolio management and agile planning with delivery insights from value stream management VSM and objectives key results OKRs.
UTRECHT, The Netherlands and CAMBRIDGE, Mass., June 29, 2023 (GLOBE NEWSWIRE) -- Merus N.V. (NASDAQ:MRUS), a clinical-stage oncology company developing innovative, full-length multispecific antibodies (Biclonics®
Planview the leading platform for connected work from portfolio planning to delivery announced today that it was named a Leader in the April 2023 Gartner Magic Quadrant for Strategic Portfolio Management1 for the second year in a row based on its Completeness of Vision and Ability to Execute.
Planview Positioned Furthest for Completeness of Vision Planview, the leading platform for connected work from portfolio planning to delivery, announced today that it was named a Leader in the April